HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Dreger Selected Research

Molecular Targeted Therapy

6/2021Allogeneic stem cell transplant in non-Hodgkin lymphomas: Still an indication?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Dreger Research Topics

Disease

46B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2022 - 03/2003
35Neoplasms (Cancer)
05/2022 - 06/2003
32Lymphoma (Lymphomas)
01/2022 - 06/2003
24Graft vs Host Disease (Graft-Versus-Host Disease)
04/2022 - 09/2006
15Leukemia
01/2021 - 10/2004
14Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2022 - 06/2003
12B-Cell Lymphoma (Lymphoma, B Cell)
11/2022 - 12/2015
12Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2021 - 01/2009
11Hematologic Neoplasms (Hematological Malignancy)
02/2022 - 06/2003
11Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2021 - 01/2009
10Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2021 - 03/2006
8Residual Neoplasm
01/2022 - 10/2004
8Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022 - 10/2015
8Multiple Myeloma
10/2020 - 06/2006
7Hodgkin Disease (Hodgkin's Disease)
11/2020 - 04/2004
6Infections
06/2022 - 06/2014
5Primary Myelofibrosis (Myelosclerosis)
01/2021 - 04/2009
4Bronchiolitis Obliterans Syndrome
10/2021 - 01/2012
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2021 - 10/2016
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020 - 12/2008
3Weight Loss (Weight Reduction)
02/2022 - 05/2015
3COVID-19
02/2022 - 10/2020
3T-Cell Lymphoma (Lymphoma, T Cell)
01/2022 - 06/2014
3Disease Progression
01/2020 - 06/2018
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2019 - 01/2008
2Sepsis (Septicemia)
01/2022 - 10/2013
2Pathologic Complete Response
11/2019 - 04/2004
2Aplastic Anemia (Anemia, Hypoplastic)
06/2019 - 01/2019
2Thrombotic Microangiopathies
10/2018 - 09/2017
2Fatigue
10/2016 - 09/2015
2Amyloidosis
01/2016 - 03/2009
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2014 - 06/2014
2Thrombocytosis (Thrombocythemia)
07/2012 - 12/2009
2Waldenstrom Macroglobulinemia (Macroglobulinemia)
06/2010 - 05/2007
1Plasma Cell Leukemia
06/2022
1Atrophy
04/2022
1Muscular Atrophy (Muscle Atrophy)
04/2022
1Breast Neoplasms (Breast Cancer)
01/2022
1Cytokine Release Syndrome
01/2022
1cell-associated neurotoxicity
01/2022
1Fibrosis (Cirrhosis)
10/2021
1Encephalitis (Encephalitis, Rasmussen)
10/2021

Drug/Important Bio-Agent (IBA)

21Chimeric Antigen ReceptorsIBA
11/2022 - 10/2016
12Rituximab (Mabthera)FDA Link
01/2021 - 01/2007
10SteroidsIBA
01/2022 - 08/2011
8Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 01/2012
7fludarabineIBA
01/2021 - 04/2004
5idelalisibIBA
02/2022 - 01/2019
4ibrutinibIBA
01/2022 - 01/2019
4Busulfan (Busulfex)FDA Link
01/2022 - 12/2009
4Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2003
4Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021 - 08/2014
4Biomarkers (Surrogate Marker)IBA
01/2021 - 03/2014
3axicabtagene ciloleucelIBA
11/2022 - 10/2021
3purineIBA
11/2019 - 12/2014
3Brentuximab VedotinIBA
01/2019 - 11/2012
2obinutuzumabIBA
04/2022 - 01/2022
2LeptinIBA
02/2022 - 05/2015
2venetoclaxIBA
01/2022 - 01/2020
2treosulfanIBA
01/2022 - 01/2020
2CytokinesIBA
10/2021 - 12/2020
2AntigensIBA
07/2021 - 06/2006
2Etoposide (VP 16)FDA LinkGeneric
01/2021 - 12/2018
2PlatinumIBA
01/2021 - 04/2018
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2018 - 03/2014
2serum P-component (CIt)IBA
06/2018 - 01/2018
2Vitamin DFDA LinkGeneric
09/2017 - 01/2017
2Azacitidine (5 Azacytidine)FDA Link
01/2017 - 08/2014
2ThrombomodulinIBA
10/2014 - 11/2012
2Alemtuzumab (Campath)FDA Link
08/2009 - 09/2006
2Peptides (Polypeptides)IBA
06/2006 - 06/2003
2Immunoglobulins (Immunoglobulin)IBA
10/2004 - 03/2003
1tisagenlecleucelIBA
05/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
04/2022
1GlucocorticoidsIBA
04/2022
16- (1H- indazol- 6- yl)- N- (4- morpholinophenyl)imidazo(1,2- a)pyrazin- 8- amineIBA
04/2022
1tirabrutinibIBA
04/2022
1Bispecific AntibodiesIBA
12/2021
1KynurenineIBA
10/2021
1Kynurenic Acid (Kynurenate)IBA
10/2021
1Vincristine (Oncovin)FDA LinkGeneric
01/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2021
1polatuzumab vedotinIBA
01/2021

Therapy/Procedure

90Stem Cell Transplantation
02/2022 - 03/2003
44Therapeutics
11/2022 - 04/2004
34Transplantation
01/2021 - 04/2004
28Cell Transplantation
06/2022 - 01/2008
24Hematopoietic Stem Cell Transplantation
04/2022 - 11/2008
15Drug Therapy (Chemotherapy)
01/2022 - 04/2004
9Homologous Transplantation
02/2022 - 11/2007
8Immunotherapy
01/2022 - 06/2018
5Autologous Transplantation
05/2019 - 04/2004
3Photopheresis
01/2022 - 01/2018
3Salvage Therapy
01/2020 - 06/2010
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2019 - 01/2016
2Cell- and Tissue-Based Therapy (Cell Therapy)
01/2020 - 01/2012
2Haploidentical Transplantation
01/2019 - 10/2017
1Resistance Training
04/2022
1Nutritional Support (Artificial Feeding)
04/2022
1Molecular Targeted Therapy
06/2021